Related Experiment Videos
Liver failure and drug metabolism
Scandinavian Journal of Gastroenterology
|January 1, 1975
Summary
Hepatic encephalopathy significantly reduces antipyrine clearance, indicating impaired liver function. This finding supports using antipyrine clearance as a prognostic tool for acute liver failure.
Area of Science:
- Hepatology
- Pharmacology
- Clinical Medicine
Background:
- Hepatic encephalopathy is a complex neurological complication of liver dysfunction.
- Assessing liver function quantitatively is crucial for managing liver disease and predicting outcomes.
Purpose of the Study:
- To investigate the impact of hepatic encephalopathy on the hepatic microsomal metabolism of antipyrine.
- To evaluate antipyrine clearance as a measure of liver function and a potential prognostic indicator.
Main Methods:
- Studied 18 patients with liver disease, measuring antipyrine metabolic clearance.
- Compared antipyrine clearance in patients during hepatic encephalopathy versus those before or after the condition.
Main Results:
- Antipyrine clearance was significantly lower in patients during hepatic encephalopathy (4.6 ml/min) compared to those before or after (9.6 ml/min).
- This demonstrates a marked reduction in hepatic microsomal metabolic activity during encephalopathy.
Conclusions:
- Antipyrine clearance serves as a valid quantitative measure of liver function.
- Antipyrine clearance shows potential as a prognostic indicator for acute liver failure.